CanFite BioPharma
Petah Tiqva
About CanFite BioPharma
Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $110.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2026)
- Ticker: otcqb:CANFY
- Website: canfite.com
- Phone: +97239241114
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/canfite-biopharma-46025 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.